Transparency Notification
THIS ANNOUNCEMENT CONTAINS REGULATED INFORMATION. PUBLICATION RELATING TO A TRANSPARENCY NOTIFICATION(ARTICLE 14, 1ST PARAGRAPH, OF THE LAW OF 2 MAY...
News
George Medicines initiates two Phase III trials of triple combination candidate to treat hypertension
George Medicines initiates two Phase III trials of triple combination candidate to treat hypertension Novel proprietary triple low-dose combination pill...
Nicox’s NCX 470 Demonstrates Significant Intraocular Pressure Lowering in Dolomites Phase 2 Glaucoma Trial
Press ReleaseNicox’s NCX 470 Demonstrates Significant Intraocular Pressure Lowering in Dolomites Phase 2 Glaucoma TrialResults Demonstrating Superior Efficacy to Current...
Sequana Medical Announces Positive Results From Second Interim Analysis of North American Pivotal alfapump® Study (POSEIDON)
Interim data from 26 patients in the Roll-In Cohort reconfirm positive outcomes against all primary endpointsiOver 90% reduction in mean...
Orchard Therapeutics and Pharming Group Announce Collaboration to Develop and Commercialize ex vivo autologous HSC Gene Therapy for Hereditary Angioedema
Highlights the broader potential of Orchard’s ex vivo HSC gene therapy platform approach in new and larger indications Reinforces Pharming’s...
Addex, Stanford University and University of Copenhagen Publish mGlu2 Structure in Nature Using Addex Allosteric Modulators
Ad Hoc Announcement Pursuant to Art. 53 LR Data could enable acceleration of lead optimization using computer aided drug discovery...
Significant Continued Progress with Formulary Uptake of BARHEMSYS® and BYFAVO™ in the US
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014. Acacia...
Bone Therapeutics secures up to €16 million loan financing from the European Investment Bank to accelerate ongoing clinical and commercial development of innovative orthopedic treatment
REGULATED INFORMATION The EIB financing to be used for Bone Therapeutics’ allogeneic cell therapy platform ALLOB and potential commercialization of...
Valneva Continues Ongoing Discussions with the European Commission for Inactivated COVID-19 Vaccine Candidate
Saint-Herblain (France), July 1, 2021 – Following a media article published yesterday, Valneva SE, (Nasdaq: VALN; Euronext Paris: VLA), a...
EXMceuticals Inc. Announces Resignation of Board Members
VANCOUVER, British Columbia, June 30, 2021 (GLOBE NEWSWIRE) -- EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the "Company" or "EXM"), announced today that...
Acumen Pharmaceuticals Announces Pricing of Upsized Initial Public Offering
CHARLOTTESVILLE, Va., June 30, 2021 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (“Acumen” or “Acumen Pharmaceuticals”) (Nasdaq: ABOS), a clinical-stage biopharmaceutical...
Aligos Therapeutics Announces Pricing of $83.6 Million Public Offering of Common Stock
SOUTH SAN FRANCISCO, Calif., June 30, 2021 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS) today announced the pricing of...
Veracyte Announces Two Pre-Eminent Physician Appointments, Further Strengthening Medical Team
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte (Nasdaq: VCYT), a global genomic diagnostics company, today announced key appointments that expand and further...
Controlling and Protecting Copiers and Printers Necessary to Secure Healthcare Data
- By Gabriela Garner, Product Marketing Director at Kofax The use of electronic health records has significantly improved the level...
Evotec Creates long-term Growth Opportunities by Initiating ‘Campus Levi-Montalcini’ in Verona
EVOTEC ACQUIRES THE VERONA SITE FROM GSK AND SECURES CAPACITY FOR LONG-TERM GROWTHEMPLOYEES VOTE FOR SITE TO BE NAMED "CAMPUS...
Klurfeld Cares Shines Light on Rare Medical Conditions Affecting Millions of Patients
Diana & Alex Klurfeld Launch ‘Klurfeld Cares' a New Awareness Website on Rare DiseasesNEW YORK, NY / ACCESSWIRE / June...
Netsmart Expands Predictive Analytics Solution Offerings with Acquisition of SimpleLTC
OVERLAND PARK, Kan.--(BUSINESS WIRE)--Today, Netsmart announced it has acquired Texas-based data analytics company SimpleLTC from Briggs Healthcare. The SimpleLTC solutions...
CureVac Final Data from Phase 2b/3 Trial of First-Generation COVID-19 Vaccine Candidate, CVnCoV, Demonstrates Protection in Age Group of 18 to 60
- Unique pivotal study conducted in 10 countries in fast changing variant environment; 15 COVID-19 variant strains present for efficacy...
AgriCann Solutions Announces Private Placement
Vancouver, British Columbia--(Newsfile Corp. - June 30, 2021) - AgriCann Solutions Corp. (the "Company" or "AgriCann"), a licensed full-service cannabis...
Cardiol Therapeutics Reports Results of 2021 Annual General and Special Meeting
Oakville, Ontario--(Newsfile Corp. - June 30, 2021) - Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) (FSE: CT9) ("Cardiol" or the...